David Greaves

The Greaves Laboratory is studying the role played by a family of inflammatory mediators called chemokines in the recruitment and activation of monocytes and macrophages during chronic inflammation. We are interested in the role chemokines play in atherosclerosis - a disease process that occurs in arteries causing angina, heart attacks, strokes and peripheral arterial disease.

We want to use our basic science understanding of inflammation biology to develop novel classes of anti-inflammatory drugs. We are using two different approaches, drug re-purposing (e.g. Purvis et al.) and chemical biology (e.g. Lucy et al.)

Current work in the laboratory seeks too identify molecules that can regulate the efficiency of macrophage phagocytosis of both microrganisms such as bacteria and apoptotic neutrophils a process called efferocytosis.